Y
Yibo Ou
Researcher at Huazhong University of Science and Technology
Publications - 13
Citations - 190
Yibo Ou is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 4, co-authored 11 publications receiving 82 citations.
Papers
More filters
Journal ArticleDOI
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
Fei Ye,Qinglei Gao,Tongjiang Xu,Liang Zeng,Yibo Ou,Feng Mao,Heping Wang,Yue He,Baofeng Wang,Zhengming Yang,Dongsheng Guo,Ting Lei +11 more
TL;DR: The study clearly indicates that LRIG1 affects cell fate and biology behaviors of the cells in vitro by inhibiting phosphorylation of downstream MAPK and AKT signaling pathway, and the elevated release level of caspase-8 might contribute to the enhanced apoptosis inLRIG1 transfected glioma cells.
Journal ArticleDOI
The Role of Iron, Its Metabolism and Ferroptosis in Traumatic Brain Injury.
TL;DR: This review will focus on the mechanisms of iron and ferroptosis involving the manifestations of TBI, and broaden the understanding of the use of iron chelators for TBI.
Journal ArticleDOI
Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke.
TL;DR: In this article, the role of the molecular mechanisms of mitochondria in energy metabolism after ischaemic stroke and new strategies for restoring energy homeostasis and neural function were discussed.
Journal ArticleDOI
The Role of Nanomaterials in Stroke Treatment: Targeting Oxidative Stress.
TL;DR: In this article, a review summarizes the characteristics and progress of nanomaterials in the application of antioxidant therapy in stroke, including ischemic stroke, hemorrhagic stroke, and neural regeneration.
Journal ArticleDOI
The Application of Brain Organoid Technology in Stroke Research: Challenges and Prospects
TL;DR: In this article, the authors summarized the application of brain organoid technology in stroke research, such as for modeling and transplantation purposes, and discussed methods to overcome the limitations of Brain Organoid technology, as well as future prospects for its application for stroke research.